Search Content | Science News

ADVERTISEMENT

REAL SCIENCE. REAL NEWS.

Help us keep you informed.

Support Science News.

Search Content

E.g., 11/15/2018
E.g., 11/15/2018
Your search has returned 59 images:
  • fish oil
  • bottle of vitamin D
  • gonorrhea bacteria
Your search has returned 86 articles:
  • News

    A potent fish oil drug may protect high-risk patients against heart attacks

    Cholesterol-lowering drugs may one day gain a sidekick in the battle against heart disease. Taking a potent drug derived from fish oil along with a statin lowers the risk of heart attack and stroke in some high-risk people, researchers report.

    A clinical trial called REDUCE-IT tested the approach in more than 8,000 participants who either had cardiovascular disease or were at high risk...

    11/10/2018 - 15:00 Health, Clinical Trials
  • News

    Vitamin D supplements don’t prevent heart disease or cancer

    CHICAGO — Taking a vitamin D supplement does not reduce the risk of having a potentially fatal heart attack or stroke or for getting an invasive cancer, according to highly anticipated results of a large clinical trial.

    The VITAL trial found no significant difference in cancer or heart health risk between people taking 2,000 international units, or IU, of vitamin D a day and those who...

    11/10/2018 - 15:00 Health, Clinical Trials
  • News in Brief

    A new drug may boost dwindling treatment options for gonorrhea

    Gonorrhea is a wily foe. But doctors may soon have another drug to fight the sexually transmitted infection that’s become resistant to nearly every antibiotic thrown its way. In clinical trials, a new antibiotic was effective at stopping the bacteria that causes the disease.

    A single oral dose of the drug, called zoliflodacin, cured 96 percent of people who had gonorrhea infections in...

    11/07/2018 - 17:00 Health, Clinical Trials
  • Feature

    How to make organ transplants last

    Trent Jackson’s life changed abruptly in early 2015. The computer engineer thought he had the flu. His then-wife, Donna Sylvia, thought differently. His skin was turning a dark golden yellow, almost brown, “like he was getting some kind of weird tan,” she says. On Wednesday, January 28, Sylvia and Jackson’s brother Todd finally persuaded Jackson to see a doctor.

    Sylvia’s suspicions were...

    10/21/2018 - 05:00 Immune Science, Cells, Clinical Trials
  • News

    New therapies pack a triple-drug punch to treat cystic fibrosis

    For years, scientists have struggled to find a therapy that works for most cystic fibrosis sufferers. Now, two new triple-drug approaches, still undergoing testing, are offering hope.

    Cystic fibrosis is caused by mutations in a gene called CFTR. These mutations mean the body either makes defective versions of a protein, also called CFTR, or none of the protein at all. The new therapies...

    10/19/2018 - 12:39 Health, Clinical Trials
  • News

    A new vaccine raises hopes of someday curbing the tuberculosis epidemic

    A new tuberculosis vaccine shows promise in preventing the bacteria from causing disease in people who are infected, but aren’t sick. If approved, it could help control the spread of a disease considered one of the world’s top killers, responsible for 1.6 million deaths in 2017, according to the World Health Organization.

    In a clinical trial, the new vaccine halved the number of people...

    09/25/2018 - 18:04 Health, Clinical Trials
  • News

    Daily low-dose aspirin is not a panacea for the elderly

    A daily dose of aspirin? Not a good idea if you’re a healthy elderly adult.

    A trio of papers based on a large-scale clinical trial finds that the drug doesn’t help to stave off heart attacks, strokes, dementia or physical disability. In fact, those in their golden years who took a low dose of aspirin daily were more likely to suffer serious internal bleeding than those who took a placebo...

    09/19/2018 - 09:30 Health, Clinical Trials
  • News

    Brain features may reveal if placebo pills could treat chronic pain

    Certain brain and personality characteristics may help predict whether a sugar pill can provide relief to someone suffering from chronic pain.

    In a small study, patients with persistent back pain who responded to a placebo treatment benefited from up to a 33 percent reduction in their pain intensity. These people had distinctive features in their brains and certain personality traits,...

    09/13/2018 - 13:00 Neuroscience, Health, Clinical Trials
  • News

    The first gene-silencing drug wins FDA approval

    A Nobel Prize–winning discovery — that small double-stranded RNA molecules can silence genes by interrupting the translation of DNA’s instructions into proteins — is finally delivering on its medical promise.

    The first drug that takes advantage of this natural biological process, called RNA interference, was approved August 10 by the U.S. Food and Drug Administration. It targets a rare...

    08/10/2018 - 15:52 Biomedicine, Clinical Trials, Health, Genetics
  • News

    Lowering blood pressure may help the brain

    Keeping a tight lid on blood pressure isn’t just good for the heart. It may also help the brain. 

    People given intensive drug treatment for high blood pressure were less likely to develop an early form of memory loss, according to preliminary results from a major clinical trial. This approach reduced the rate of early memory loss, called mild cognitive impairment, by around 19 percent,...

    07/25/2018 - 09:00 Health, Clinical Trials, Neuroscience